These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the interaction between the bacterial superantigen streptococcal pyrogenic exotoxin A (SpeA) and the human T-cell receptor. Kline JB; Collins CM Mol Microbiol; 1997 Apr; 24(1):191-202. PubMed ID: 9140976 [TBL] [Abstract][Full Text] [Related]
7. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. Proft T; Arcus VL; Handley V; Baker EN; Fraser JD J Immunol; 2001 Jun; 166(11):6711-9. PubMed ID: 11359827 [TBL] [Abstract][Full Text] [Related]
8. Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner. Kasper KJ; Zeppa JJ; Wakabayashi AT; Xu SX; Mazzuca DM; Welch I; Baroja ML; Kotb M; Cairns E; Cleary PP; Haeryfar SM; McCormick JK PLoS Pathog; 2014 May; 10(5):e1004155. PubMed ID: 24875883 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice. Pandey M; Calcutt A; Ozberk V; Chen Z; Croxen M; Powell J; Langshaw E; Mills JL; Jen FE; McCluskey J; Robson J; Tyrrell GJ; Good MF Sci Adv; 2019 Sep; 5(9):eaax3013. PubMed ID: 31517054 [TBL] [Abstract][Full Text] [Related]
10. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells. Imanishi K; Igarashi H; Uchiyama T J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113 [TBL] [Abstract][Full Text] [Related]
11. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S; Faulkner L; Hopkins P Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999 [TBL] [Abstract][Full Text] [Related]
12. Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A. Müller-Alouf H; Proft T; Zollner TM; Gerlach D; Champagne E; Desreumaux P; Fitting C; Geoffroy-Fauvet C; Alouf JE; Cavaillon JM Infect Immun; 2001 Jun; 69(6):4141-5. PubMed ID: 11349089 [TBL] [Abstract][Full Text] [Related]
13. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections. Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Kline JB; Collins CM Infect Immun; 1996 Mar; 64(3):861-9. PubMed ID: 8641793 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. Papageorgiou AC; Collins CM; Gutman DM; Kline JB; O'Brien SM; Tranter HS; Acharya KR EMBO J; 1999 Jan; 18(1):9-21. PubMed ID: 9878045 [TBL] [Abstract][Full Text] [Related]
16. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Arad G; Levy R; Hillman D; Kaempfer R Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148 [TBL] [Abstract][Full Text] [Related]
17. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Kuo CF; Wu JJ; Lin KY; Tsai PJ; Lee SC; Jin YT; Lei HY; Lin YS Infect Immun; 1998 Aug; 66(8):3931-5. PubMed ID: 9673282 [TBL] [Abstract][Full Text] [Related]
18. Two novel superantigens found in both group A and group C Streptococcus. Proft T; Webb PD; Handley V; Fraser JD Infect Immun; 2003 Mar; 71(3):1361-9. PubMed ID: 12595453 [TBL] [Abstract][Full Text] [Related]
19. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Smoot LM; McCormick JK; Smoot JC; Hoe NP; Strickland I; Cole RL; Barbian KD; Earhart CA; Ohlendorf DH; Veasy LG; Hill HR; Leung DY; Schlievert PM; Musser JM Infect Immun; 2002 Dec; 70(12):7095-104. PubMed ID: 12438391 [TBL] [Abstract][Full Text] [Related]
20. SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles. Dominguez-Medina CC; Rash NL; Robillard S; Robinson C; Efstratiou A; Broughton K; Parkhill J; Holden MTG; Lopez-Alvarez MR; Paillot R; Waller AS Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]